Shares of ValiRx plc (LON:VAL – Get Rating) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 16.21 ($0.19) and traded as high as GBX 17.95 ($0.21). ValiRx shares last traded at GBX 17.75 ($0.21), with a volume of 613,121 shares.
ValiRx Trading Up 0.3 %
The stock has a market cap of £16.05 million and a PE ratio of -7.72. The business’s fifty day moving average is GBX 16.21 and its 200 day moving average is GBX 16.50. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 1.77.
ValiRx Company Profile
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- Want to Get a 10% Dividend Yield, Look Here
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.